PortfoliosLab logo

ARCA biopharma, Inc. (ABIO)

Equity · Currency in USD · Last updated Jun 30, 2022

Company Info

ISINUS00211Y5069
CUSIP00211Y506
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.50
Year Range$1.77 - $3.74
EMA (50)$2.35
EMA (200)$2.52
Average Volume$74.07K
Market Capitalization$36.03M

ABIOShare Price Chart


Chart placeholderClick Calculate to get results

ABIOPerformance

The chart shows the growth of $10,000 invested in ARCA biopharma, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10 for a total return of roughly -99.90%. All prices are adjusted for splits and dividends.


ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

ABIOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M3.31%-8.16%
YTD16.28%-19.88%
6M12.11%-20.21%
1Y-30.17%-11.00%
5Y-43.49%9.57%
10Y-39.27%10.88%

ABIOMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ABIOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ARCA biopharma, Inc. Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

ABIODividend History


ARCA biopharma, Inc. doesn't pay dividends

ABIODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

ABIOWorst Drawdowns

The table below shows the maximum drawdowns of the ARCA biopharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ARCA biopharma, Inc. is 99.97%, recorded on Jan 28, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.97%Mar 29, 20102982Jan 28, 2022
-23.92%Jan 12, 201050Mar 24, 20102Mar 26, 201052
-1.22%Jan 5, 20101Jan 5, 20102Jan 7, 20103

ABIOVolatility Chart

Current ARCA biopharma, Inc. volatility is 39.62%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ABIO (ARCA biopharma, Inc.)
Benchmark (^GSPC)

Portfolios with ARCA biopharma, Inc.


Loading data...